A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1997
11/13/1997	WO1997041839A1 Taste masked liquid suspensions
11/13/1997	WO1997041838A1 Non-aqueous colonic purgative formulations
11/13/1997	WO1997041837A2 Microparticles
11/13/1997	WO1997041836A1 Pharmaceutical compositions for the sustained release of insoluble active principles
11/13/1997	WO1997041835A1 Improvement in the taste of active pharmaceutical ingredients
11/13/1997	WO1997041834A1 Cationic virosomes as transfer system for genetic material
11/13/1997	WO1997041833A1 Dispersible macromolecule compositions and methods for their preparation and use
11/13/1997	WO1997041832A1 Suspension of sparingly water-soluble acidic drug
11/13/1997	WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997	WO1997041830A1 Reparation and prevention of fibrotic lesions
11/13/1997	WO1997041742A1 Oil containing lipid vesicles with marine applications
11/13/1997	WO1997037640A3 Uniform drug delivery therapy
11/13/1997	WO1997033563A3 Fluorocarbons for diagnosis and treatment of articular disorders
11/13/1997	DE19619150A1 Microparticles, useful in formulations of active agent
11/13/1997	CA2258909A1 Oil containing lipid vesicles with marine applications
11/13/1997	CA2253919A1 Reparation and prevention of fibrotic lesions
11/13/1997	CA2253798A1 Polymer powders redispersible in aqueous solution
11/13/1997	CA2253737A1 Micellar aqueous composition and method for solubilizing hydrophobic drug
11/13/1997	CA2253649A1 Hollow bone mineral-like calcium phosphate particles
11/13/1997	CA2253561A1 Cationic virosomes as transfer system for genetic material
11/13/1997	CA2253557A1 Treatment of asthma with tnfr-ig
11/13/1997	CA2253386A1 Improvement in the taste of active pharmaceutical ingredients
11/13/1997	CA2253377A1 Pharmaceutical compositions for the sustained release of insoluble active principles
11/13/1997	CA2253260A1 Suspension of sparingly water-soluble acidic drug
11/13/1997	CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	CA2248552A1 Stabilization of sol-gel derived silica-based glass
11/13/1997	CA2204067A1 Chlorhexidine glucomate-containing, stabilized aqueous pharmaceutical preparations
11/12/1997	EP0806433A2 Compostable and thermoplastically processable mixed ether-2-hydroxycarboxylic acid ester of cellulose and mixed ester
11/12/1997	EP0806206A1 Aqueous compositions containing ciprofloxacine, and related use and process
11/12/1997	EP0806202A1 Controlled release pharmaceutical composition containing stabilized lipophilic matrices
11/12/1997	EP0805822A1 Spray dried erythropoietin
11/12/1997	EP0805689A1 A stabilized pharmaceutical formulation comprising a growth hormone and x-lys
11/12/1997	EP0805683A1 5-carboxamido or 5-fluoro]- 2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/12/1997	EP0805680A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	EP0805677A1 Extended release clonidine formulation
11/12/1997	EP0805676A1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
11/12/1997	EP0805675A1 Directly compressible high load acetaminophen formulations
11/12/1997	EP0730465A4 Use of angiotensin iii and analogs thereof in tissue repair
11/12/1997	EP0480982B2 Vaccines and vectors with liquid active principles containing an oil which can be metabolised
11/12/1997	CN2267048Y Protective adhesive for finger skin wound
11/12/1997	CN2267043Y Adhesive plaster for treating hemorrhoid
11/12/1997	CN2267042Y Medicinal pellets characterised in the form of food
11/12/1997	CN1164828A Oral cyclosporin formulations
11/12/1997	CN1164561A Stable W/O/W emulsion containing water-sensitive cosmetic and/or dermatological active principle
11/12/1997	CN1164424A Controlled-release composition
11/12/1997	CN1164418A Magnetic disinfectant antipruritic spray for preventing and curing venereal disease and its preparing method
11/12/1997	CN1164408A Sheep blood powder preparation and its preparing method
11/12/1997	CN1164402A Drug preparation Sanru oral liquor for curing hyperplasia of mammary glands
11/12/1997	CN1164400A Method for preparation of drug for curing cataract of livestock
11/12/1997	CN1164399A Banmuxuelingdan capsule
11/12/1997	CN1164398A Easy-to-use reparcussive pain-stopping plaster
11/12/1997	CN1164392A Method for preparing compound tobramycin suspension for eye
11/12/1997	CN1164389A Extended release formulation
11/12/1997	CN1164387A Stable carotenoid emulsions suitable for parenteral administration
11/12/1997	CN1164386A Common bletilla tuber hellow capsule
11/12/1997	CN1036375C Local drug delivery film for periodontal treatment
11/11/1997	US5686632 Method of producing a tocopherol product
11/11/1997	US5686620 Cationic phospholipids for transfection
11/11/1997	US5686440 Containing lactic acid as a solubilizer and an additive
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686296 Yeast debris products
11/11/1997	US5686133 Gelatin and lecithin
11/11/1997	US5686116 Administering a group iiia element-containing compound
11/11/1997	US5686115 Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
11/11/1997	US5686113 Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
11/11/1997	US5686112 Single dosage semi-solid topical pharmaceutical forms for transdermal therapy
11/11/1997	US5686111 Animal food supplement briquette
11/11/1997	US5686109 Antipyretic analgesic composition
11/11/1997	US5686107 Chewable pharmaceutical tablets
11/11/1997	US5686106 Cellulose acetate phthalate enteric coating
11/11/1997	US5686105 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
11/11/1997	US5686104 Stable oral CI-981 formulation and process of preparing same
11/11/1997	US5686103 Liposomal product with a ligand having fucose as a terminal moiety
11/11/1997	US5686102 Asymmetric, lamellar aggregates containing phospholipids, drug, and fluorocarbon
11/11/1997	US5686101 Phospholipid derivative and liposome containing it
11/11/1997	US5686100 Prophylactic and therapeutic treatment of skin sensitization and irritation
11/11/1997	US5686099 Method and device for the release of drugs to the skin
11/11/1997	US5686098 Active substance patch for the release of estradiol to the skin
11/11/1997	US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate
11/11/1997	US5686094 Calcium polycarbophil
11/11/1997	US5686092 Growth promoters for animals
11/11/1997	US5686089 Tissue moisturizing and antimicrobial compositions
11/11/1997	US5686088 Moisturizing, clotrimazole, polyacrylamide gelling agent, polypropylene fabric
11/11/1997	US5686060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography
11/11/1997	CA2024502C Dosage form for administering oral hypoglycemic glipizide
11/10/1997	CA2204701A1 Compostable and thermoplastic cellulose ether-2-hydroxy-carboxylic acid esters and mixed esters
11/08/1997	CA2194656A1 Partially lyophilized fructose-1,6-diphosphate (fdp) for injection into humans
11/06/1997	WO1997040858A1 Novel dispersible lipid blends and uses therefor
11/06/1997	WO1997040850A1 Erythropoietin solution preparation
11/06/1997	WO1997040828A1 Rapid-release s1452 tablets
11/06/1997	WO1997040824A2 Propellant mixtures and aerosols for micronising medicaments with compressed gas
11/06/1997	WO1997040823A1 Oral pharmaceutical compositions containing sex hormones
11/06/1997	WO1997040822A2 Delivery device
11/06/1997	WO1997040821A1 A method of preparing a dosage unit by direct tableting and product therefrom
11/06/1997	WO1997040820A1 Recipient-dosage delivery system
11/06/1997	WO1997040819A1 Methods of dry powder inhalation
11/06/1997	WO1997040818A1 Biologically active composition
11/06/1997	WO1997040792A1 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers
11/06/1997	WO1997040776A1 Synchronising of animal oestrus and intra vaginal devices useful therein

1 ... 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 ... 2991